{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:42:34Z","timestamp":1791859354070,"version":"4.3.4"},"reference-count":36,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.3892\/mmr.2012.1117","type":"journal-article","created":{"date-parts":[[2012,10,8]],"date-time":"2012-10-08T09:09:44Z","timestamp":1349687384000},"page":"237-241","source":"Crossref","is-referenced-by-count":91,"title":["CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis"],"prefix":"10.3892","volume":"7","author":[{"given":"JILONG","family":"WU","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MIAONI","family":"ZHOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YINSHENG","family":"WAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AIE","family":"XU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2012,10,8]]},"reference":[{"key":"key20180108012038_b1-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1084\/jem.192.11.1637","article-title":"Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of T cell-mediated vitiligo","volume":"192","author":"Yee","year":"2000","journal-title":"J Exp Med"},{"key":"key20180108012038_b2-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1172\/JCI0214643","article-title":"The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo","volume":"109","author":"Kemp","year":"2002","journal-title":"J Clin Invest"},{"key":"key20180108012038_b3-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1523-1747.2001.01408.x","article-title":"Specific cytotoxic T lymphocyte responses against Melan-A\/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex\/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo","volume":"117","author":"Palermo","year":"2001","journal-title":"J Invest Dermatol"},{"key":"key20180108012038_b4-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1042\/CS20090603","article-title":"Vitiligo, reactive oxygen species and T-cells (Review)","volume":"120","author":"Glassman","year":"2011","journal-title":"Clin Sci (Lond)"},{"key":"key20180108012038_b5-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000131485","article-title":"Autoimmune etiology of generalized vitiligo (Review)","volume":"10","author":"Le Poole","year":"2008","journal-title":"Curr Dir Autoimmun"},{"key":"key20180108012038_b6-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00262-007-0415-z","article-title":"Langerhans cells and dendritic cells are cytotoxic towards HPV16 E6 and E7 expressing target cells","volume":"57","author":"Le Poole","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"key20180108012038_b7-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1034\/j.1600-0749.2003.00023.x","article-title":"Evidence for an autoimmune pathogenesis of vitiligo (Review)","volume":"16","author":"Ongenae","year":"2003","journal-title":"Pigment Cell Res"},{"key":"key20180108012038_b8-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.1711700209","article-title":"An immunohistological study of cutaneous lymphocytes in vitiligo","volume":"170","author":"Badri","year":"1993","journal-title":"J Pathol"},{"key":"key20180108012038_b9-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/01.LAB.0000069521.42488.1B","article-title":"Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo","volume":"83","author":"Wankowicz-Kalinska","year":"2003","journal-title":"Lab Invest"},{"key":"key20180108012038_b10-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1034\/j.1600-0749.2003.00038.x","article-title":"Melanocyte-specific immune response in melanoma and vitiligo: two faces of the same coin?","volume":"16","author":"Wankowicz-Kalinska","year":"2003","journal-title":"Pigment Cell Res"},{"key":"key20180108012038_b11-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2133.2000.03712.x","article-title":"Expression and modulation of apoptosis regulatory molecules in human melanocytes: significance in vitiligo","volume":"143","author":"van den Wijngaard","year":"2000","journal-title":"Br J Dermatol"},{"key":"key20180108012038_b12-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/labinvest.3780138","article-title":"Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site","volume":"80","author":"van den Wijngaard","year":"2000","journal-title":"Lab Invest"},{"key":"key20180108012038_b13-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/1523-1747.ep12470172","article-title":"The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin","volume":"88","author":"Bos","year":"1987","journal-title":"J Invest Dermatol"},{"key":"key20180108012038_b14-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2307\/2531541","article-title":"Sample size determination in clinical trials with an emphasis on exponentially distributed responses","volume":"43","author":"Gross","year":"1987","journal-title":"Biometrics"},{"key":"key20180108012038_b15-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"van den Boorn","year":"2009","journal-title":"J Invest Dermatol"},{"key":"key20180108012038_b16-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1468-3083.2010.03824.x","article-title":"Treatment of vitiligo in children and adolescents by autologous cultured pure melanocytes transplantation with comparison of efficacy to results in adults","volume":"25","author":"Hong","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key20180108012038_b17-mmr-07-01-0237","first-page":"520","article-title":"Ratio of size of recipient and donor areas in treatment of vitiligo by autologous cultured melanocyte transplantation","volume":"165","author":"Hong","year":"2011","journal-title":"Br J Dermatol"},{"key":"key20180108012038_b18-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/1523-1747.ep12289743","article-title":"Alterations in IL-6, IL-8, GM-CSF, TNF-alpha, and IFN-gamma release by peripheral mononuclear cells in patients with active vitiligo","volume":"108","author":"Yu","year":"1997","journal-title":"J Invest Dermatol"},{"key":"key20180108012038_b19-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1034\/j.1600-0749.2002.1o049.x","article-title":"New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions","volume":"15","author":"Moretti","year":"2002","journal-title":"Pigment Cell Res"},{"key":"key20180108012038_b20-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archderm.138.2.273","article-title":"Vitiligo and epidermal microenvironment: possible involvement of keratinocyte-derived cytokines","volume":"138","author":"Moretti","year":"2002","journal-title":"Arch Dermatol"},{"key":"key20180108012038_b21-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0923-1811(02)00151-2","article-title":"Increased interleukin-6 and granulocyte-macrophage colony stimulating factor levels in the sera of patients with non-segmental vitiligo","volume":"31","author":"Tu","year":"2003","journal-title":"J Dermatol Sci"},{"key":"key20180108012038_b22-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cytogfr.2011.02.003","article-title":"IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer (Review)","volume":"22","author":"Neurath","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"key20180108012038_b23-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ejcb.2010.10.007","article-title":"The soluble Interleukin 6 receptor: generation and role in inflammation and cancer","volume":"90","author":"Chalaris","year":"2011","journal-title":"Eur J Cell Biol"},{"key":"key20180108012038_b24-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-2133.1995.tb02714.x","article-title":"Cutaneous metastatic angiosarcoma with a lethal outcome, following radiotherapy for a cervical carcinoma","volume":"133","author":"Krasagakis","year":"1995","journal-title":"Br J Dermatol"},{"key":"key20180108012038_b25-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-642-78771-3_12","article-title":"Growth control of melanoma cells and melanocytes by cytokines","volume":"139","author":"Krasagakis","year":"1995","journal-title":"Recent Results Cancer Res"},{"key":"key20180108012038_b26-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF01105076","article-title":"Tumour necrosis factors and several interleukins inhibit the growth and modulate the antigen expression of normal human melanocytes in vitro","volume":"287","author":"Krasagakis","year":"1995","journal-title":"Arch Dermatol Res"},{"key":"key20180108012038_b27-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1755-148X.2011.00945.x","article-title":"Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris","volume":"25","author":"Kotobuki","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"key20180108012038_b28-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clim.2008.08.018","article-title":"The effects of IL-6 on CD4 T cell responses (Review)","volume":"130","author":"Dienz","year":"2009","journal-title":"Clin Immunol"},{"key":"key20180108012038_b29-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1084\/jem.20081571","article-title":"The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells","volume":"206","author":"Dienz","year":"2009","journal-title":"J Exp Med"},{"key":"key20180108012038_b30-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejphar.2010.02.026","article-title":"Anti-IL-6 receptor antibody suppressed T cell activation by inhibiting IL-2 production and inducing regulatory T cells","volume":"634","author":"Yoshida","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"key20180108012038_b31-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00296-010-1552-9","article-title":"IL-6 blockade preferentially inhibits Th17 differentiation in collagen-induced arthritis","volume":"31","author":"Yoshida","year":"2011","journal-title":"Rheumatol Int"},{"key":"key20180108012038_b32-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molimm.2008.12.019","article-title":"Properties and origin of human Th17 cells (Review)","volume":"47","author":"Romagnani","year":"2009","journal-title":"Mol Immunol"},{"key":"key20180108012038_b33-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.4049\/jimmunol.161.7.3694","article-title":"Essential roles of Lyn in fibronectin-mediated filamentous actin assembly and cell motility in mast cells","volume":"161","author":"Suzuki","year":"1998","journal-title":"J Immunol"},{"key":"key20180108012038_b34-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00130832-200210000-00004","article-title":"Genetics of IL-13 and functional relevance of IL-13 variants (Review)","volume":"2","author":"Vercelli","year":"2002","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"key20180108012038_b35-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.0105-2896.2004.00210.x","article-title":"Opposing roles for IL-13 and IL-13 receptor alpha 2 in health and disease (Review)","volume":"202","author":"Mentink-Kane","year":"2004","journal-title":"Immunol Rev"},{"key":"key20180108012038_b36-mmr-07-01-0237","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1073\/pnas.0305064101","article-title":"IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis","volume":"101","author":"Mentink-Kane","year":"2004","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2012.1117\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T03:54:41Z","timestamp":1687751681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2012.1117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,8]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,10,8]]},"published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.3892\/mmr.2012.1117"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2012.1117","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,8]]}}}